Single-nucleotide polymorphisms associated with symptomatic infection and differential human gene expression in healthy seropositive persons each implicate the cytoskeleton, integrin signaling, and oncosuppression in the pathogenesis of human parvovirus B19 infection

Journal of Infectious Diseases

Volumn 192, Issue 2, 2005, Pages 276-286

  Kerr, Jonathan R ^a,f   Kaushik, Narendra ^a   Fear, David ^c   Baldwin, Don A ^e   Nuwaysir, Emile F ^d   Adcock, Ian M ^b  

^a St Mary's Campus ^*  (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d Roche NimbleGen Inc   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOSKELETON PROTEIN; DNA DIRECTED RNA POLYMERASE III; GENOMIC DNA; INTEGRIN; RNA; RNA POLYMERASE II; UBIQUITIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFANT; MALE; NUCLEOTIDE SEQUENCE; PARVOVIRUS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM; UNINDEXED SEQUENCE; VIRUS INFECTION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYTOSKELETON; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INTEGRINS; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; SIGNAL TRANSDUCTION;

EID: 22244458539     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/430950     Document Type: Article

References (28)

1. Anderson MJ, Higgins PG, Davis LR, et al. Experimental parvovirual infection in humans. J Infect Dis 1985; 152:257-65.
2. Kerr JR, Barah F, Mattey DL, et al. Circulating tumour necrosis factor-α and interferon-aγ are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol 2001; 82:3011-19.
3. Takeda S, Takaeda C, Takazakura E, Haratake J. Renal involvement induced by human parvovirus B19 infection. Nephron 2001; 89:280-5.
4. Kerr JR, Mattey DL, Thomson W, Poulton KV, Ollier WER. Association of symptomatic acute human parvovirus B19 infection with HLA class I and II alleles. J Infect Dis 2002; 186:447-52.
5. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002; 15:485-505.
6. Kerr JR. The pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis 2000; 59:672-83.
7. Kerr JR, Bracewell J, Laing I, et al. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection. J Rheumatol 2002; 29: 595-602.
8. Barah F, Vallely PJ, Chiswick ML, Cleator GM, Kerr JR. Human parvovirus B19 infection associated with acute meningoencephalitis. Lancet 2001; 358:729-30.
9. Lindblad-Toh K, Tanenbaum DM, Daly MJ, et al. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat Biotechnol 2000; 18:1001-5.
10. Lo HS, Wang Z, Hu Y, et al. Allelic variation in gene expression is common in the human genome. Genome Res 2003; 13:1855-62.
11. Nuwaysir EF, Huang W, Albert TJ, et al. Gene expression analysis using oligonucleotide arrays produced by maskless photolithography. Genome Res 2002; 12:1749-55.
12. Hicks KE, Cubel RC, Cohen BJ, Clewley JP. Sequence analysis of a parvovirus B19 isolate and baculovirus expression of the non-structural protein. Arch Virol 1996; 141:1319-27.
13. Kerr JR, Cartron JP, Curran MD, Moore JE, Elliott JR, Mollan RA. A study of the role of parvovirus B19 in rheumatoid arthritis. Br J Rheumatol 1995; 34:809-13.
14. Lehmann HW, von Landenberg P, Modrow S. Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2003; 2:218-23.
15. Kerr JR, Cunniffe VS, Kelleher P, Coats AJ, Mattey DL. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis. J Med Virol 2004; 74:147-55.
16. Kotin RM, Linden RM, Berns KI. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J 1992; 11:5071-8.
17. Kotin RM, Siniscalco M, Samulski RJ, et al. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 1990; 87:2211-5.
18. Corsini J, Tal J, Winocour E. Directed integration of minute virus of mice DNA into episomes. J Virol 1997; 71:9008-15.
19. Reed JL, Kucukcetin B, Koenig S. Mechanisms of parvovirus B19 persistence in peripheral blood mononuclear cells (PBMC). Infect Dis Rev 2000; 2:169.
20. Segovia JC, Guenechea G, Gallego JM, Almendral JM, Bueren JA. Parvovirus infection suppresses long-term repopulating hematopoietic stem cells. J Virol 2003; 77:8495-503.
21. Weigel-Kelley KA, Yoder MC, Srivastava A. α5β1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of β1 integrin for viral entry. Blood 2003; 102:3927-33.
22. Suikkanen S, Aaltonen T, Nevalainen M, et al. Exploitation of microtubule cytoskeleton and dynein during parvoviral traffic toward the nucleus. J Virol 2003; 77:10270-9.
23. Ros C, Burckhardt CJ, Kempf C. Cytoplasmic trafficking of minute virus of mice: low-pH requirement, routing to late endosomes, and proteasome interaction. J Virol 2002; 76:12634-45.
24. Kerr JR, McCoy M, Burke B, Mattey DL, Pravica V, Hutchinson IV Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection. J Clin Pathol 2003; 56:725-7.
25. Rommelaere J, Cornelis JJ. Antineoplastic activity of parvoviruses. J Virol Methods 1991; 33:233-51.
26. Katagiri K, Maeda A, Shimonaka M, Kinashi T. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat Immunol 2003; 4:741-8.
27. Aoyama Y, Avruch J, Zhang XF. Norel inhibits tumor cell growth independent of Ras or the MST1/2 kinases. Oncogene 2004; 23:3426-33.
28. Cox AD, Der CJ. The dark side of Ras: regulation of apoptosis. Oncogene 2003; 22:8999-9006.